| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.03 | 0.8 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |